Navigation Links
RRD Announces Move to New Corporate Headquarters

ROCKVILLE, Md., Sept. 9 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that they have moved to expanded offices this month.  The new office space, located at 7361 Calhoun Place, Rockville, MD, recently completed build-out and more than doubles RRD's business footprint to 13,000 sq ft.

"This move is symbolic of the growth and success RRD has achieved in the last year," said Scott Tarrant, Chief Business Officer, RRD International. "Our model has proven time and again to be more efficient and successful than traditional methods, and the market's increasing demand for RRD services necessitated finding a new space to accommodate our growing needs."

RRD International delivers tactical, regulatory-driven product development support to companies and investors in the life sciences industry. Leveraging its in-house strategic and operational expertise, the Company helps clients better plan, manage and execute product development. Having successfully completed more than 80 product development engagements with a wide range of organizations, RRD International's fully integrated development team works to enable rapid proof of concept, reduce costs, and accelerate value creation.

"Times of growth and change are always exciting," added Chuck Finn, President and CEO, RRD International.  "We're thrilled to have found a place that lets us remain in Rockville and better serve our clients and partners."

About RRD International

Founded in 2002, RRD is a strategy-driven product development company. The Company's development model enables rapid proof of concept for biotech and pharmaceutical clients to accelerate value inflection points; reduce costs; and mitigate development as well as execution risk. RRD offers two distinct types of client engagements: TacDev® and DevCo®. The TacDev® model adds development bandwidth and expertise for defined products in companies with minimal infrastructure. The DevCo® model creates external product development companies where investment is in asset optimization rather than traditional infrastructure. For more information visit: RRD International: Accelerating the Right Development; Creating Lasting Value.

SOURCE RRD International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd.
2. Martek Announces Third Quarter FY 2010 Financial Results
3. ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells
4. Medisafe 1 Technologies Announces 1-5 Stock Dividend
5. DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System - Orcathermâ„¢
6. EUSA Pharma Announces the Appointment of Stephen A. Stamp to its Board of Directors
7. Biodel Announces Name Change for Lead Product Candidate
8. Enerkem Announces Construction Start of Worlds First Municipal Waste-to-Biofuels Facility in Edmonton, Alberta
9. MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
10. Glenmark Announces the Discovery of a Novel Chemical Entity GRC 17536, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally
11. ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... India , November 26, 2015 ... The Global Biobanking Market 2016 - 2020 report ... by maintaining integrity and quality in long-term samples, ... enabling long-term cost-effectiveness. Automation minimizes manual errors such ... the technical efficiency. Further, it plays a vital ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
Breaking Biology Technology:
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/20/2015)... Connecticut , November 20, 2015 ... authentication company focused on the growing mobile commerce market ... CEO, Gino Pereira , was recently interviewed on ... interview will air on this weekend on Bloomberg ... Latin America . --> NXTD ) ("NXT-ID" ...
(Date:11/19/2015)... 2015  Based on its in-depth analysis of the ... with the 2015 Global Frost & Sullivan Award for ... presents this award to the company that has developed ... of the market it serves. The award recognizes the ... on customer base demands, the overall impact it has ...
Breaking Biology News(10 mins):